Suppr超能文献

用于治疗疾病的定向富集、扩增和募集调节性细胞的策略。

Strategies to direct the enrichment, expansion, and recruitment of regulatory cells for the treatment of disease.

作者信息

Glowacki Andrew J, Gottardi Riccardo, Yoshizawa Sayuri, Cavalla Franco, Garlet Gustavo P, Sfeir Charles, Little Steven R

机构信息

Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Ann Biomed Eng. 2015 Mar;43(3):593-602. doi: 10.1007/s10439-014-1125-2. Epub 2014 Sep 23.

Abstract

Disease and injury perturb the balance of processes associated with inflammation and tissue remodeling, resulting in positive feedback loops, exacerbation of disease and compromised tissue repair. Conversely, under homeostatic healthy conditions, these processes are tightly regulated through the expansion and/or recruitment of specific cell populations, promoting a balanced steady-state. Better understanding of these regulatory processes and recent advances in biomaterials and biotechnology have prompted strategies to utilize cells for the treatment and prevention of disease through regulation of inflammation and promotion of tissue repair. Herein, we describe how cells that regulate these processes can be increased in prevalence at a site of disease or injury. We review several relevant cell therapy approaches as well as new strategies for directing endogenous regulatory cells capable of promoting environmental homeostasis and even the establishment of a pro-regenerative micro-environment. Collectively, these examples may provide a blueprint for next-generation "medicine" that spurs the body's own cells to action and replaces conventional drugs.

摘要

疾病和损伤会扰乱与炎症和组织重塑相关的过程平衡,导致正反馈循环、疾病恶化以及组织修复受损。相反,在稳态健康条件下,这些过程通过特定细胞群体的扩增和/或募集受到严格调控,从而促进平衡的稳态。对这些调控过程的深入理解以及生物材料和生物技术的最新进展促使人们采取策略,通过调节炎症和促进组织修复,利用细胞来治疗和预防疾病。在此,我们描述了如何在疾病或损伤部位增加调控这些过程的细胞数量。我们回顾了几种相关的细胞治疗方法以及引导内源性调节细胞的新策略,这些细胞能够促进环境稳态甚至建立促再生微环境。总体而言,这些例子可能为下一代“药物”提供蓝图,促使人体自身细胞发挥作用并取代传统药物。

相似文献

3
Regulatory T Cell-Mediated Tissue Repair.调节性 T 细胞介导的组织修复。
Adv Exp Med Biol. 2018;1064:221-233. doi: 10.1007/978-981-13-0445-3_14.
5
Regenerative medicine in kidney disease: where we stand and where to go.肾脏疾病中的再生医学:现状与展望。
Pediatr Nephrol. 2018 Sep;33(9):1457-1465. doi: 10.1007/s00467-017-3754-9. Epub 2017 Jul 22.
10
Endogenous cell recruitment strategy for articular cartilage regeneration.用于关节软骨再生的内源性细胞招募策略。
Acta Biomater. 2020 Sep 15;114:31-52. doi: 10.1016/j.actbio.2020.07.008. Epub 2020 Jul 8.

引用本文的文献

本文引用的文献

5
Cytokines in inflammatory bowel disease.炎症性肠病中的细胞因子。
Nat Rev Immunol. 2014 May;14(5):329-42. doi: 10.1038/nri3661. Epub 2014 Apr 22.
6
Gelatin carriers for drug and cell delivery in tissue engineering.用于组织工程中药物和细胞递送的明胶载体
J Control Release. 2014 Sep 28;190:210-8. doi: 10.1016/j.jconrel.2014.04.014. Epub 2014 Apr 16.
7
Engaging adaptive immunity with biomaterials.利用生物材料激发适应性免疫。
J Mater Chem B. 2014 May 7;2(17):2409-2421. doi: 10.1039/C3TB21549K.
10
Engineering vaccines and niches for immune modulation.设计用于免疫调节的疫苗和生态位。
Acta Biomater. 2014 Apr;10(4):1728-40. doi: 10.1016/j.actbio.2013.12.036. Epub 2013 Dec 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验